ciprofloxacin has been researched along with Mediastinal Diseases in 3 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Mediastinal Diseases: Disorders of the mediastinum, general or unspecified.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Tularemia is a zoonosis transmitted either directly from infected animals or indirectly via tick or mosquito bites, inhalation of contaminated dust or ingestion of contaminated water." | 1.51 | [Mediastinal Lymphadenopathy - Tuberculosis or Tularemia?] ( Geerdes-Fenge, HF; Löbermann, M; Reisinger, EC; Warnke, P; Zimpfer, A, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Geerdes-Fenge, HF | 1 |
| Löbermann, M | 1 |
| Warnke, P | 1 |
| Zimpfer, A | 1 |
| Reisinger, EC | 1 |
| Greten, T | 1 |
| Hautmann, H | 1 |
| Trauner, A | 1 |
| Huber, RM | 1 |
| Mayer, TA | 1 |
| Bersoff-Matcha, S | 1 |
| Murphy, C | 1 |
| Earls, J | 1 |
| Harper, S | 1 |
| Pauze, D | 1 |
| Nguyen, M | 1 |
| Rosenthal, J | 1 |
| Cerva, D | 1 |
| Druckenbrod, G | 1 |
| Hanfling, D | 1 |
| Fatteh, N | 1 |
| Napoli, A | 1 |
| Nayyar, A | 1 |
| Berman, EL | 1 |
1 review available for ciprofloxacin and Mediastinal Diseases
| Article | Year |
|---|---|
[Esophagomediastinal fistulae as a rare complication of tuberculosis in an HIV-infected patient].
Topics: AIDS-Related Opportunistic Infections; Ciprofloxacin; Drug Therapy, Combination; Esophageal Fistula; | 1994 |
2 other studies available for ciprofloxacin and Mediastinal Diseases
| Article | Year |
|---|---|
[Mediastinal Lymphadenopathy - Tuberculosis or Tularemia?]
Topics: Aged; Anti-Bacterial Agents; Ciprofloxacin; Diagnosis, Differential; Humans; Lymphadenopathy; Male; | 2019 |
Clinical presentation of inhalational anthrax following bioterrorism exposure: report of 2 surviving patients.
Topics: Anthrax; Anti-Bacterial Agents; Bacillus anthracis; Bioterrorism; Blood; Ciprofloxacin; Clindamycin; | 2001 |